PT - JOURNAL ARTICLE AU - Irma Querques AU - Michael Schmitz AU - Seraina Oberli AU - Christelle Chanez AU - Martin Jinek TI - Molecular mechanism of target site selection and remodeling by type V CRISPR-associated transposons AID - 10.1101/2021.07.06.451292 DP - 2021 Jan 01 TA - bioRxiv PG - 2021.07.06.451292 4099 - http://biorxiv.org/content/early/2021/07/06/2021.07.06.451292.short 4100 - http://biorxiv.org/content/early/2021/07/06/2021.07.06.451292.full AB - Although the canonical function of CRISPR-Cas systems is to provide adaptive immunity against mobile genetic elements1, type I-F, I-B and V-K systems have been adopted by Tn7-like transposons to direct RNA-guided transposon insertion2–7. Type V-K CRISPR-associated transposons rely on the activities of the pseudonuclease Cas12k, the transposase TnsB, the AAA+ ATPase TnsC and the zinc-finger protein TniQ7. However, the molecular and structural details of RNA-directed DNA transposition have remained elusive. Here we report cryo-electron microscopic structures of a Cas12k-guide RNA-target DNA complex and a DNA-bound, polymeric TnsC filament. The Cas12k complex structure reveals an intricate guide RNA architecture and critical interactions mediating RNA-guided target DNA recognition. The assembly of the TnsC helical filament is ATP-dependent and accompanied by structural remodeling of the bound DNA duplex. In vivo transposition assays corroborate key features of the structures, and biochemical experiments further show that TniQ restricts TnsC polymerization, while the TnsB transposase interacts directly with TnsC filaments to trigger their disassembly upon ATP hydrolysis. Together, these results suggest a mechanistic model whereby RNA-directed target selection by Cas12k primes TnsC polymerization and DNA remodeling, generating a recruitment platform for TnsB to catalyze site-specific transposon insertion. The present work advances our mechanistic understanding of the cross-talk between CRISPR effectors and the transposition machinery and will inform design efforts to harness CRISPR-associated transposons as programmable site-specific gene insertion tools for genome engineering applications.Competing Interest StatementThe authors have declared no competing interest.